bpc-157 clinicaltrials.gov Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review BPC-157 with Cryotherapy for Ultra-Fast
Description
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways

Struggling to remember recent conversations or feeling confused about familiar information is different

Weiss LG

Clin Cancer Res 27:27552763
This breaks down to approximately: 1.7mg GHK-Cu 0.33mg BPC-157 0.33mg TB-500 Use a 0.3ml (30-unit) insulin syringe for greater measurement precision at these low volumes
